Innovative Medicines Initiative

About IMI

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safe medicines for patients.IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA. Read more

Ebola+ Programme

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. The Ebola+ programme exemplifies how such multi-faceted collaborative efforts can have a stronger impact than any single player could alone. IMI2 offers a unique opportunity to complement the ongoing European and international efforts against Ebola.

Read more

From Twitter

RT @sinieskola: @EFPIA @PGEU @EPSA_Online #medsdisposal campaign gets some limelight at @FIPCongress today https://t.co/Y6jPgsBkHp about 8 hours ago by EFPIA
RT @eupatients: We want your FEEDBACK: Guidance on patients + industry interactions #eupatients #patientsinvolved... https://t.co/IGGEYAkHqD 4 days ago by EFPIA